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Abstract
Background: The inhibition of penicillin-binding protein 2a (PBP2a) is a promising solution in overcoming resistance
of methicillin resistance Staphylococcus aureus (MRSA). A potential approach in achieving this is by combining natural
product with currently available antibiotics to restore the activity as well as to amplify the therapeutic ability of the
drugs. We studied inhibition effects of a bioactive fraction, F-10 (isolated from the leaves of Duabanga grandiflora)
alone and in combination with a beta-lactam drug, ampicillin on MRSA growth and expression of PBP2a.
Additionally, phytochemical analysis was conducted on F-10 to identify the classes of phytochemicals present.
Methods: Fractionation of the ethyl acetate leaf extract was achieved by successive column chromatography
which eventually led to isolation of an active fraction, F-10. Both extract and F-10 were analyzed for the presence
of major classes of phytochemicals in addition to obtaining a high performance liquid chromatography (HPLC)
profile to reveal the complexity of the fraction F-10. Broth microdilution method was employed to determine
minimum inhibitory concentration (MIC) of the extract and fractions against MRSA. Evaluation of synergistic
activity of the active fraction with ampicillin was determined using checkerboard methodand kinetic growth
experiments. Effect of combination treatments on expression of PBP2a, a protein that confers resistance to
beta-lactam antibiotics, was elucidated with the Western blot assay.
Results: MIC of F-10 against MRSA was 750 mg/L which showed an improved activity by 4-fold compared to its
crude extract (MIC = 3000 mg/L). Phytochemical analysis revealed occurrence of tannins, saponin, flavonoids,
sterols, and glycosides in F10 fraction. In FIC index interpretation, the most synergistic activity was achieved for
combinations of 1/64 × MIC ampicillin + 1/4 × MIC F-10. The combination also evidently inhibited MRSA growth
in kinetic growth curve assay. As a result of this synergistic interaction, MIC of ampicillin against MRSA was
reduced to 0.78 mg/L (64-fold) from initial value of 50 mg/L. Western blot analysis suggested inhibition of
PBP2a in MRSA cultures grown in synergistic combination treatment in which no PBP2a band was expressed.
Conclusions: The results demonstrated synergism between fraction F-10 of D. grandiflora with ampicillin in
suppressing MRSA growth via PBP2a inhibition.
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Background
Resistance issue of MRSA continues to threaten the
world population despite the availability of new anti-
biotics [1]. At present, MRSA infections are not only
seen in hospital but also in community and livestock [2].
Prevalence of this infection underlies in its resistance
mechanism. Primarily, acquisition of mecA gene confers
resistance in S. aureus to methicillin. This gene encodes
for production of a reduced-affinity penicillin-binding
protein 2a (PBP2a) which was first discovered in 1981
[3]. The low binding affinity of PBP2a to beta-lactams
enables peptidoglycan cell wall synthesis in MRSA des-
pite the presence of lethal concentration of methicillin
[4, 5]. Considering MRSA’s resistance, future quest of
antimicrobials should be focused in finding solutions to
inhibit production of PBP2a and restoring beta-lactams
activity.
A plausible approach to treat infections caused by
deleterious pathogens and to tackle its complex multi-
drug resistance issues is by applying the concept of
synergism [6]. Phytomedicine essentially, offers a new
alternative for synergy treatment consisting combi-
nation of phytomedicine with commercially available
antibiotics [7–9]. Duabanga grandiflora (Roxb. Ex DC)
Walp, belongs to the Lythraceae family and it is indi-
genous to Eastern Himalayas [10, 11]. In India, the
paste from the plant has been widely utilized to cure
skin diseases, mainly eczema or atopic dermatitis (AD)
[12]. Advancement in dermatological research indi-
cated link between S. aureus infection and AD based
on skin lesion caused by the bacteria and identification
of S. aureus delta toxin in skin sample of AD patients
[13, 14]. These findings show that ethnobotanical use
of D. grandiflora in treating eczema may actually have
relation to its ability to heal bacterial infections namely
S. aureus.
In our earlier study we have shown that ethyl acetate
extract from D. grandiflora possessed broad spectrum
antimicrobial action including anti-staphylococcal acti-
vity [15, 16]. Based on this rationale, in the present study
we investigated the synergistic effects of a bioactive frac-
tion, F-10 from D. grandiflora,with ampicillin on MRSA
growth. In order to better understand the molecular
mechanism, effects of the combination treatment on the
resistant protein, PBP2a was investigated. Chemical and
HPLC analyses were conducted to identify the presence
of major classes of compounds in the fraction as well as
to gain a better insight into its complexity.
Methods
Plant material
D. grandiflora leaves were collected from a growing tree
in Simpang Pulai, Pahang, Malaysia (GPS location: N04°
33.701’ E101° 11.685’) and identified by Dr. Christophe
Wiart from the School of Pharmacy. Herbarium voucher
specimens (herbarium code UNMC75) are deposited
at the Herbarium of Faculty of Science, University of
Nottingham Malaysia Campus. The dried and ground
plant materials (2.1 kg – D. grandiflora leaves) was
subjected to sequential extraction using n-hexane (He),
followed by ethyl acetate (EA) and finally 95 % ethanol
(EtOH). Extraction with each solvent was conducted by
soaking the plant material in 10 L of the solvent (24 h ×
3 times) at room temperature [16, 17].
Isolation of F-10
The ethyl acetate extract of D. grandiflora leaves was frac-
tionated by using vacuum liquid chromatography (silica
gel). The solvent system used for elution was chloroform
(CHCl3) in decreasing amount of hexane (He) or CHCl3 in
increasing amount of methanol (MeOH), i.e., He/CHCl3
(1:1)→CHCl3 (100 %)→CHCl3/MeOH (3 %)→CHCl3/
MeOH(5 %)→CHCl3/MeOH (7 %)→CHCl3/MeOH
(10 %)→CHCl3/MeOH (15 %). The column was finally
flushed with EtOH. Fraction F-10 eluted in solvent system
CHCl3/MeOH (15 %).
Microorganisms
Methicillin sensitive S. aureus ATCC 11632 (MSSA) was
grown in tryptic soy broth (TSB) (Hi-Media, India) at
37 °C for 24 h with a shaking mode of 220 rpm. Aliquot
from this suspension was streaked on tryptic soy agar
(TSA) (Hi-Media, India) and incubated at 37 °C for
another 24 h. Two to four single colonies from the TSA
plate was inoculated in 10 ml of Muller Hinton broth
(MHB) (Hi-Media, India) and allowed to grow at 37 °C
until it reached exponential stage (2 × 108 CFU/ml). The
suspension then was used for broth microdilution assay.
MRSA ATCC 43300 was grown with same steps except
all the media used for its growth was supplemented with
2 % sodium chloride (NaCl) (Merck, Germany) and
incubation temperature was 35 °C. Bacterial stocks were
kept at −80 °C in TSB added with 10 % (vol/vol) glycerol
(Sigma, USA).
Test samples
The ethyl acetate crude extract of D. grandiflora and frac-
tion F-10 were dissolved in dimethyl sulfoxide (DMSO)
(Sigma, USA) at stock concentration of 1000 mg/L. The
stock kept in −20 °C for experiments. Antibiotics for sus-
ceptibility testing prepared at 100 mg/L in sterile distilled
water. Tested antibiotics were ampicilin (Amresco, USA),
oxacillin (Discovery Fine Chemicals, UK) and methicillin
(Sigma, USA).
Determination of minimum inhibitory concentration (MIC)
Microbroth dilution method using a 96-well microtitier
plate was used to determine MIC of crude extract
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D. grandiflora, fraction F-10 and control antibiotics
against MRSA and MSSA. Antibiotics were tested with
concentrations ranging from 0.19 to 100 mg/L and plant
extract samples from 90 to 12,000 mg/L. Bacterial sus-
pensions were prepared according to methods described
above (section microorganism). Bacterial broth cultures
were diluted to correspond to final inoculums of 5 ×
105 CFU/ml upon inoculation into each well containing
two-fold serial dilution of test samples. This experiment
was done according to guidelines from Clinical and
Laboratory Standards Institute (CLSI) 2007 [18] with
recommendations adapted from Cos et al. [19].
Fractional inhibitory concentration (FIC) index
interpretation- Checkerboard method
This experiment was conducted according to a previously
described checkerboard method [20]. MRSA cultures were
grown in presence of the following sub-inhibitory
concentrations of F-10; 1/4 × MIC (188 mg/L), 1/8 ×
MIC (94 mg/L),1/16 × MIC (47 mg/L), and 1/32 ×
MIC (23 mg/L) in combination with sub-inhibitory
concentrations of ampicillin ranging from 1/2 × MIC to
1/64 × MIC (25 mg/L to 0.78 mg/L). This experiment was
conducted on a 96-well microtiter plate with test sam-
ples and bacterial suspension prepared in same manner
as for MIC determination except wells now contained
combined test samples (F-10 and ampicillin).
FIC index for the combination treatments were calcu-
lated. The formula used was:
FIC ampicillin ¼ MIC of ampicillin in combination
MIC of ampicillin alone
FIC plant extract ¼ MIC of plant extract in combination
 MIC of plant extract alone
FIC index ¼ FIC of ampicillin þ FIC of plant extract
The combination was defined as synergy if the FIC
index is ≤ 0.5, indifference was defined as when FIC index
is > 0.5 but ≤ 4.0, and antagonism was defined as when
FIC index is > 4.0 [20]. The combination of two test
samples; ampicillin and fraction F-10 was graphically
described by a Cartesian diagram using isobole method
for combinations that lowered MIC ampicillin. A straight
line indicates no interaction and a concave isobole shows
synergism between the tested components [21].
Kinetic growth curves assay
The experiment was conducted for combination which
lowered the MIC of ampicillin for MRSA from 50 mg/L
to 0.78 mg/L (1/64 of the original MIC). The test sam-
ples and bacterial inoculums were prepared as the same
for FIC interpretation on a 96- well microtiter plate. Cell
growth was monitored by reading optical density (OD)
values at 600 nm at indicated time points for 24 h. Read-
ing was monitored by using Varioskan flash multimode
reader (Thermo Scientific, USA).
Western blotting analysis
MRSA culture was grown in combination treatment
consisting of 1/64 × MIC ampicillin + 1/4 ×MIC F-10
until late exponential phase (24 h). Bacterial protein was
extracted by preparing the lysates in an extraction buffer
containing Tris and EDTA (Thermo Scientific, USA).
Following 15-min of centrifugation at 18,500 g, the pel-
lets were obtained as the insoluble protein extracts
which was harvested in elution buffer containing Tris,
urea and sodium dihydrogen phosphate. Extracted pro-
tein (3 mg/L) was subjected to sodium dodecyl sulfate
(SDS) - polyacrylamide (12 %) gel electrophoresis ran at
120 V, and then transferred to BioTrace™ NT nitrocellu-
lose transfer membrane (Pall, USA). The production of
PBP2a from MRSA was detected by probing the mem-
branes with mouse anti-PBP2a primary antibody (Denka
Seiken, Japan) and anti-glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) (Thermo Scientific, USA) with
dilution factor of 1:10000. The same membranes were
re-probed with anti-mouse horseradish peroxidase-linked
secondary antibody (Abcam, UK) diluted to 1:10000 to fa-
cilitate colorimetric detection with 3, 3’, 5, 5’-tetramethyl-
benzidine (TMB) substrate (Nacalai Tesque, Japan). Assay
response was recorded using GS-800™ calibrated densi-
tometer (Bio-Rad, USA). Results were recorded based on
visual band intensity.
Phytochemical analysis
Phytochemical analysis for the ethyl acetate crude
extract of D. grandiflora leaves and fraction F-10 was
carried out according to methods described by Jones
and Kinghorn [22].
High performance liquid chromatography (HPLC) analysis
An aliquot of fraction F-10 (40 μl of 10 mg/ml) was ana-
lyzed by reverse phase HPLC (C18) using the following
gradient solvent system: 2 min at 10 % acetonitrile
(ACN)/miliQ water (H2O); a linear gradient to 75 %
ACN/H2O over 12 min; isocratic at 75 % for 10 min; a
linear gradient to 100 % ACN for 2 min; isocratic at
100 % ACN for 4 min. HPLC was performed on a Varian
940-LC system using a reversed phase analytical column
(Pursuit XRs C18, 4.6 × 150 mm, 5 μm) with photodiode
array (PDA) detection at 254 nm.
Results
Anti-MRSA activities of D. grandiflora leaf extract and
fraction F-10
The MIC values for MRSA are higher than MSSA for
the tested antibiotics confirming the resistance of the
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strain used in this study. D. grandiflora leaf extract
showed a moderate antimicrobial activity against MRSA
and MSSA with same MIC value. The MIC value for
fraction F-10 however showed a 4-fold reduction indi-
cating an increased antimicrobial activity against MRSA
and MSSA. Table 1 shows the MIC results for tested
antibiotics, D. grandiflora extract and F-10.
Synergistic effects of ampicillin and fraction F-10 against
MRSA FIC index
In FIC index interpretation, 10 out of 24 tested combi-
nation treatments indicated synergism (results not shown).
Table 2 shows the new MIC values of ampicillin against
MRSA achieved by combination treatments for four most
synergistic combinations along with the corresponding FIC
index values. It is noteworthy that the presence of F-10 re-
markably reduced the MIC of ampicillin against MRSA.
The most notable change in the MIC of ampicillin was ob-
served when 1/4 ×MIC of F-10 was added, where the MIC
was reduced by 64-fold from 50 mg/L to 0.78 mg/L.
The appreciable synergistic effects observed for the
combination 1/64 × MIC ampicillin + 1/4 ×MIC F-10 is
further supported by the isobole concave curve for the
MIC of the two components, ampicillin and F-10 (Fig. 1).
Effects of ampicillin and F-10 alone and in combination
on MRSA growth curves
Kinetic growth curves of combinations of ampicillin and
fraction F-10 demonstrated synergistic effects in inhibiting
growth of MRSA over a period of 24 h (Fig. 2). The pres-
ence of F-10 alone at sub-inhibitory concentrations (1/4 ×
MIC) suppressed the bacterial growth up to 50 % compared
to control MRSA. Ampicillin at sub-inhibitory concentra-
tion (1/64 × MIC) suppressed the growth of MRSA by 8 %
only after 24-h of incubation. Nevertheless, in combination
treatment, the growth of MRSA was markedly inhibited.
Inhibition of PBP2a expression in MRSA by combination
of ampicillin with F-10
The expression of PBP2a in MRSA in treatment of
1/64 × MIC ampicillin + 1/4 × MIC F-10 was studied.
The controls include untreated MRSA, untreated MSSA
and MRSA grown in only one test sample (ampicillin or
F-10) at sub-inhibitory concentrations that were same as
in the combination treatment. Figure 3 depicts expres-
sion of PBP2a in each treatment. MSSA did not express
any PBP2a band and a clear protein band (76 kDa) was
seen in MRSA cultures. The intensity of PBP2a expres-
sion in MRSA cultures that were exposed to 1/64 x MIC
ampicillin was higher compared to untreated MRSA
(See Fig. 3, lane 3 and lane 2, respectively). MRSA cul-
ture treated with F-10 alone appeared to have attenu-
dated PBP2a expression compared to control MRSA (see
lane 4). In combination treatment, presence of F-10 and
ampicillin (both at sub-inhibitory level), totally inhibited
the expression of PBP2a. Control GAPDH was expressed
in all controls and treatment.
Classes of phytochemicals and HPLC analysis of
fraction F-10
Phytochemical evaluation of the crude extract indicated
the presence tannins, alkaloids, flavonoids, saponins,
Table 1 Minimum inhibitory concentration (MIC) of test
samples for MRSA ATCC 43300 and MSSA ATCC 11632. Values
represent triplicates of three independent experiments
MIC (mg/L)




Leaf ethyl acetate extract
D. grandiflora
3000 3000
Fraction F-10 750 750
Table 2 FIC indices combination of fraction F-10 of D. grandiflora
leaf extract with ampicillin against MRSA ATCC 43300. Values
represent triplicates of three independent experiments




1/4 × MIC (188) 0.78 0.25
1/8 × MIC (94) 3.13 0.18
1/16 × MIC (47) 12.5 0.31
1/32 × MIC (23) 12.5 0.28
aFIC index; synergism ≤ 0.5, indifference >0.5 but ≤ 4.0, and antagonism > 4




















Fig. 1 Isobole MIC curve. Isobole MIC curve for MRSA ATCC 43300
describing synergism between ampicillin and fraction F-10 of
D. grandiflora leaf extract at sub-inhibitory concentrations
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sterols and glycosides, while fraction F-10 contain simi-
lar classes of compounds, except alkaloid (Table 3).
HPLC chromatogram (Fig. 4) of fraction F-10 revealed
five broad chromatographic peaks at 254 nm. These
peaks appeared when the mobile phase composition was
75 % ACN/H2O, taking place between 12 to 16 min.
The chromatogram indicated severe overlapping of indi-
vidual compound peak due to incomplete separation,
which suggested that F-10 comprised a complex mixture
of phytochemicals and this is consistent with the phyto-
chemical analysis.
Discussion
Medicinal use of D. grandiflora is to treat ailments asso-
ciated with skin diseases [12] which may worsen with
bacterial and viral infection due the patient’s suscepti-
bility [23]. Consistently, MIC evaluation indicated that
the crude ethyl acetate extract and fraction F-10 possess
antibacterial properties against MRSA and MSSA based
on their antimicrobial activities. Deduction from the
MIC and FIC index evaluations coupled with results
from the kinetic growth assay concluded that components
in F-10 act synergistically with ampicillin in inhibiting
MRSA’s growth. This was evidently demonstrated by re-
duction of MIC ampicillin from 50 mg/L to 0.78 mg/L in
the presence of 1/4 × MIC of F-10.
Prompted by these results, we investigated the combi-
nation’s mechanisms of action on MRSA and found it is
linked to PBP2a inhibition. Shimizu et al. [24] reported
that corilagin from Arctostaphylos uva-ursi was able to
inhibit PBP2a production and subsequently increased
the potency of beta-lactam antibiotics. Based on the
Western blot analysis, we confirmed that combination of
F-10 with ampicillin (both at sub-inhibitory concentra-
tion) totally suppressed the expression of PBP2a in
MRSA. The noteworthy observation here is F-10 alone
could only attenuate PBP2a expression in MRSA and by
combining this fraction with ampicillin, a complete
inhibition on PBP2a was achieved. We postulated that
F-10 interferes with the regulatory genes involved in
the expression of mecA that encodes for PBP2a expres-



























1/64 x MIC Amp (0.78 
mg/L)
1/4 x MIC F-10 (188 
mg/L)
1/64 x MIC Amp + 1/4 x 
MIC F-10
Control MRSA
Fig. 2 Growth curves of MRSA ATCC 43300. MRSA cultures were grown in sub-inhibitory concentrations of fraction F-10 alone, ampicillin alone
and in combination. Cell growth was measured by using optical density at 600 nm at indicated time points. The curves represent triplicates of three
independent experiments. Error bars show the standard deviation ( 1/64 × MIC Amp, 1/4 × MIC F-10, combination of
Amp+ F-10, control MRSA, Amp= ampicillin, MIC =minimum inhibitory concentration)
Fig. 3 Inhibition of PBP2a expression in MRSA ATCC 43300.
Lane: 1 - control MSSA ATCC 11632, 2 - control MRSA ATCC 43300,
3 - ampicillin 0.78 mg/L, 4 - fraction F-10 188 mg/L, 5 - ampicillin
0.78 mg/L + fraction F-10 188 mg/L. Scoring of visual band
intensity; − absence of band, + presence of band, ++ presence of
strong band, +++ presence of very strong band (black vertical lines
in between the gel lanes indicate the image has been juxtaposed
but within the same gel)
Table 3 Qualitative analysis of phytochemical contents of
D. grandiflora leaves extract and fraction F-10
Phytochemicals D. grandiflora leaves extract F-10




Sterols + + +
Glycosides + + + +
Results represent triplicates of an independent experiment (+ present,
+ + moderate amount, + + + appreciable amount, −absence)
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controlled by the mecR1-mecI-mecR2 regulatory gene.
It was reported that this very unique three-component
arrangement, consisting of a transcriptional repressor
(mecI), a sensor-inducer (mecR1) and an anti-repressor
(mecR2), is vital for full expression of the mecA gene
[26–28]. In brief, exposure of beta-lactams to MRSA
stimulates mecR1-mecI-mecR2 genes of mecA regula-
tory locus, which leads to robust induction of mecA
transcription. As a consequence, unique modulation of
proteolytic cleavage series takes place, eventually cau-
sing complete expression of beta-lactam resistance such
as PBP2a production [26]. Hence, intrusion of F-10
with any of these regulatory genes might interrupt the
three-component arrangement system, consequently
preventing synthesis of PBP2a or full induction of mecA
that is vital for resistance expression. Nevertheless, the
possibility that the antibacterial effects of F-10 is caused
by several mechanisms cannot be ruled out since this
fraction essentially contains a cocktail of naturally occur-
ring compounds.
Phytochemical analysis showed occurrence of tannins,
flavonoids, saponins, sterols, and glycosides in F-10.
Same phytochemicals were detected in D. grandiflora
extracts reported in a different study that demonstrated
anti-staphylococcal activities [15]. The phytochemical
analysis also provided insight into possible mechanisms
of action. Flavonoids and tannins found in F10 have
been shown to be toxic to microorganism due sites and
numbers of hydroxyl group that has non nonspecific
interactions with the protein or able to cause enzyme
inhibition [29, 30]. Since PBPs are group of protein
enzymes [31], these phytochemicals could form non-
specific interaction with them. Interaction as this may
affect the bacterial cell biosynthesis process eventually
leading to MRSA growth inhibition as demonstrated in
our synergy growth curve experiment. Furthermore, it
is likely that the same non-specific interaction may
have also caused inhibition of PBP2a expression in our
study. Besides that sterols and glycosides were also found
in F-10. Plant sterols were proven to have antibacterial
properties [32], and several glycoside compounds were re-
ported to exhibit antimicrobial activities against MRSA
[33]. It appears that a number of possible phytochemicals
detected in F-10 could contribute to the anti-MRSA
activity.
Our study indicates that F-10 has anti-MRSA properties
and resulted in greater inhibitory activity when used with
ampicillin in the in-vitro assays. Synergism of antimicro-
bial effect in this study is linked to inhibition of PBP2a
expression. As such F-10 is potentially a good can-
didate for development of new treatment regime for
MRSA. Subsequent experiments are crucial to study
the pharmacokinetics properties of the fraction and its
interaction with ampicillin in an in vivo model. Besides,
the interactions of F-10 with the regulatory genes,
mecI-mecR1-mecR2 and their resultant proteins leading
to the inhibition phenomenon remained to be solved
and require additional investigations.
Conclusions
Our data revealed that a bioactive fraction F-10 isolated
from D. grandiflora possesses antimicrobial activity.
Anti-MRSA evaluation showed that this fraction works
synergistically with ampicillin in hindering growth of the
bacteria. The ability of F10 to attenuate the production
of PBP2a is postulated to result in the restoration of the
susceptibility of MRSA to ampicillin.
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